|
Systagenix Wound Management
|
|
Systagenix connect there heritage of trust and innovation with there focused commitment to developing wound healing solutions based on evidence. They offer a full line of products and an integrated approach to treatment in the field of wound care, including products that actively promote wound healing, control bacteria and help maintain a moist wound healing environment. By continually enhancing product line, it is this enduring mission to bring solutions that help heal patient with a wound. With around 800 employees worldwide and a production facility in Gargrave, North Yorkshire, UK, Systagenix distributes products and services to more than a hundred countries. A State of the Art technology centre, located within production facility, accommodates an internationally recognised research and development team. Systagenix is a notable investment of One Equity Partners, that it is comes from divestiture of Professional Wound Care Business to One Equity Partners from Ethicon Inc., a franchise of Johnson & Johnson Medical. . See Also
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
